Short course induction immunosuppression with thymoglobulin for renal transplant recipients

Irfan A. Agha, Jose Rueda, Alejandro Alvarez, Gary G. Singer, Brent W. Miller, Karen Flavin, Jeffrey A. Lowell, Surendra Shenoy, Todd K. Howard, Venkataraman Ramachandran, William Irish, Mark A. Schnitzle, Daniel C. Brennan

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Background. The aim of this study was to demonstrate that 3-days of induction immunosuppression with thymoglobulin was as effective and safe as a 7-day course and reduced initial hospitalization after transplantation. Methods. This was a prospective, nonrandomized trial of 40 consecutive patients receiving thymoglobulin induction for 3 days and followed for 1 year. An historical group of 48 patients that received 7 days of thymoglobulin served as controls. Results. At 1 year, acute rejection (5 vs. 4%), graft survival (95vs. 98%) and patient survival were similar; a composite end point of freedom from death, rejection, or graft loss, the event-free graft survival, was similar as was the safety profile. In the 3-day group, lymphocyte depletion was more sustained and initial hospitalization was significantly shorter (6 vs. 8 days). Conclusion. Three-day induction with thymoglobulin is as effective and safe as seven days, decreases initial hospitalization and causes more sustained lymphocyte depletion.

Original languageEnglish (US)
Pages (from-to)473-475
Number of pages3
JournalTransplantation
Volume73
Issue number3
StatePublished - Feb 15 2002
Externally publishedYes

Fingerprint

Immunosuppression
Lymphocyte Depletion
Kidney
Hospitalization
Graft Survival
Graft Rejection
Disease-Free Survival
Transplantation
Safety
Survival
Transplant Recipients
thymoglobulin

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Agha, I. A., Rueda, J., Alvarez, A., Singer, G. G., Miller, B. W., Flavin, K., ... Brennan, D. C. (2002). Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation, 73(3), 473-475.

Short course induction immunosuppression with thymoglobulin for renal transplant recipients. / Agha, Irfan A.; Rueda, Jose; Alvarez, Alejandro; Singer, Gary G.; Miller, Brent W.; Flavin, Karen; Lowell, Jeffrey A.; Shenoy, Surendra; Howard, Todd K.; Ramachandran, Venkataraman; Irish, William; Schnitzle, Mark A.; Brennan, Daniel C.

In: Transplantation, Vol. 73, No. 3, 15.02.2002, p. 473-475.

Research output: Contribution to journalArticle

Agha, IA, Rueda, J, Alvarez, A, Singer, GG, Miller, BW, Flavin, K, Lowell, JA, Shenoy, S, Howard, TK, Ramachandran, V, Irish, W, Schnitzle, MA & Brennan, DC 2002, 'Short course induction immunosuppression with thymoglobulin for renal transplant recipients', Transplantation, vol. 73, no. 3, pp. 473-475.
Agha IA, Rueda J, Alvarez A, Singer GG, Miller BW, Flavin K et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation. 2002 Feb 15;73(3):473-475.
Agha, Irfan A. ; Rueda, Jose ; Alvarez, Alejandro ; Singer, Gary G. ; Miller, Brent W. ; Flavin, Karen ; Lowell, Jeffrey A. ; Shenoy, Surendra ; Howard, Todd K. ; Ramachandran, Venkataraman ; Irish, William ; Schnitzle, Mark A. ; Brennan, Daniel C. / Short course induction immunosuppression with thymoglobulin for renal transplant recipients. In: Transplantation. 2002 ; Vol. 73, No. 3. pp. 473-475.
@article{63a57b642a854ddcbc079a0c8e9af9a9,
title = "Short course induction immunosuppression with thymoglobulin for renal transplant recipients",
abstract = "Background. The aim of this study was to demonstrate that 3-days of induction immunosuppression with thymoglobulin was as effective and safe as a 7-day course and reduced initial hospitalization after transplantation. Methods. This was a prospective, nonrandomized trial of 40 consecutive patients receiving thymoglobulin induction for 3 days and followed for 1 year. An historical group of 48 patients that received 7 days of thymoglobulin served as controls. Results. At 1 year, acute rejection (5 vs. 4{\%}), graft survival (95vs. 98{\%}) and patient survival were similar; a composite end point of freedom from death, rejection, or graft loss, the event-free graft survival, was similar as was the safety profile. In the 3-day group, lymphocyte depletion was more sustained and initial hospitalization was significantly shorter (6 vs. 8 days). Conclusion. Three-day induction with thymoglobulin is as effective and safe as seven days, decreases initial hospitalization and causes more sustained lymphocyte depletion.",
author = "Agha, {Irfan A.} and Jose Rueda and Alejandro Alvarez and Singer, {Gary G.} and Miller, {Brent W.} and Karen Flavin and Lowell, {Jeffrey A.} and Surendra Shenoy and Howard, {Todd K.} and Venkataraman Ramachandran and William Irish and Schnitzle, {Mark A.} and Brennan, {Daniel C.}",
year = "2002",
month = "2",
day = "15",
language = "English (US)",
volume = "73",
pages = "473--475",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Short course induction immunosuppression with thymoglobulin for renal transplant recipients

AU - Agha, Irfan A.

AU - Rueda, Jose

AU - Alvarez, Alejandro

AU - Singer, Gary G.

AU - Miller, Brent W.

AU - Flavin, Karen

AU - Lowell, Jeffrey A.

AU - Shenoy, Surendra

AU - Howard, Todd K.

AU - Ramachandran, Venkataraman

AU - Irish, William

AU - Schnitzle, Mark A.

AU - Brennan, Daniel C.

PY - 2002/2/15

Y1 - 2002/2/15

N2 - Background. The aim of this study was to demonstrate that 3-days of induction immunosuppression with thymoglobulin was as effective and safe as a 7-day course and reduced initial hospitalization after transplantation. Methods. This was a prospective, nonrandomized trial of 40 consecutive patients receiving thymoglobulin induction for 3 days and followed for 1 year. An historical group of 48 patients that received 7 days of thymoglobulin served as controls. Results. At 1 year, acute rejection (5 vs. 4%), graft survival (95vs. 98%) and patient survival were similar; a composite end point of freedom from death, rejection, or graft loss, the event-free graft survival, was similar as was the safety profile. In the 3-day group, lymphocyte depletion was more sustained and initial hospitalization was significantly shorter (6 vs. 8 days). Conclusion. Three-day induction with thymoglobulin is as effective and safe as seven days, decreases initial hospitalization and causes more sustained lymphocyte depletion.

AB - Background. The aim of this study was to demonstrate that 3-days of induction immunosuppression with thymoglobulin was as effective and safe as a 7-day course and reduced initial hospitalization after transplantation. Methods. This was a prospective, nonrandomized trial of 40 consecutive patients receiving thymoglobulin induction for 3 days and followed for 1 year. An historical group of 48 patients that received 7 days of thymoglobulin served as controls. Results. At 1 year, acute rejection (5 vs. 4%), graft survival (95vs. 98%) and patient survival were similar; a composite end point of freedom from death, rejection, or graft loss, the event-free graft survival, was similar as was the safety profile. In the 3-day group, lymphocyte depletion was more sustained and initial hospitalization was significantly shorter (6 vs. 8 days). Conclusion. Three-day induction with thymoglobulin is as effective and safe as seven days, decreases initial hospitalization and causes more sustained lymphocyte depletion.

UR - http://www.scopus.com/inward/record.url?scp=0037084271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037084271&partnerID=8YFLogxK

M3 - Article

VL - 73

SP - 473

EP - 475

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -